ANL 22.33 Decreased By ▼ -1.86 (-7.69%)
ASC 14.69 Decreased By ▼ -0.51 (-3.36%)
ASL 23.40 Increased By ▲ 1.40 (6.36%)
BOP 8.28 Decreased By ▼ -0.14 (-1.66%)
BYCO 8.20 Decreased By ▼ -0.26 (-3.07%)
FCCL 17.87 Increased By ▲ 0.47 (2.7%)
FFBL 23.40 Decreased By ▼ -0.82 (-3.39%)
FFL 16.12 Decreased By ▼ -0.78 (-4.62%)
FNEL 7.95 Decreased By ▼ -0.20 (-2.45%)
GGGL 19.32 Decreased By ▼ -1.37 (-6.62%)
GGL 41.49 Decreased By ▼ -0.04 (-0.1%)
HUMNL 6.28 Decreased By ▼ -0.27 (-4.12%)
JSCL 19.42 Decreased By ▼ -0.71 (-3.53%)
KAPCO 37.19 Decreased By ▼ -0.31 (-0.83%)
KEL 3.50 Decreased By ▼ -0.01 (-0.28%)
MDTL 2.78 Decreased By ▼ -0.17 (-5.76%)
MLCF 35.00 Decreased By ▼ -0.05 (-0.14%)
NETSOL 140.00 Decreased By ▼ -4.85 (-3.35%)
PACE 5.15 Decreased By ▼ -0.82 (-13.74%)
PAEL 28.42 Decreased By ▼ -1.67 (-5.55%)
PIBTL 8.88 Decreased By ▼ -0.29 (-3.16%)
POWER 7.32 Decreased By ▼ -0.28 (-3.68%)
PRL 18.26 Decreased By ▼ -0.99 (-5.14%)
PTC 9.91 Decreased By ▼ -0.21 (-2.08%)
SILK 1.50 Decreased By ▼ -0.12 (-7.41%)
SNGP 45.50 Increased By ▲ 2.00 (4.6%)
TELE 20.41 Decreased By ▼ -1.59 (-7.23%)
TRG 169.20 Decreased By ▼ -1.30 (-0.76%)
UNITY 33.10 Decreased By ▼ -0.84 (-2.47%)
WTL 2.98 Decreased By ▼ -0.11 (-3.56%)
BR100 4,818 Decreased By ▼ -39.63 (-0.82%)
BR30 23,454 Decreased By ▼ -411.52 (-1.72%)
KSE100 45,568 Decreased By ▼ -440.51 (-0.96%)
KSE30 18,023 Decreased By ▼ -156.09 (-0.86%)

Coronavirus
VERY HIGH Source: covid.gov.pk
Pakistan Deaths
27,374
4724hr
Pakistan Cases
1,230,238
2,33324hr
4.56% positivity
Sindh
452,267
Punjab
424,701
Balochistan
32,796
Islamabad
104,472
KPK
171,874

AstraZeneca

Key insights from US trial data on AstraZeneca's COVID-19 vaccine
World

Key insights from US trial data on AstraZeneca's COVID-19 vaccine

  • The trial results, primarily generated in the United States but also in Chile and Peru, included a 79% efficacy in preventing symptomatic COVID-19, and showed no increased risk of a rare form of blood clots that has caused concern in parts of Europe.
  • Britain's Medicines and Healthcare products Regulatory Agency concluded at the time that a 12-week gap between doses was the key to achieving the highest efficacy, of around 80%.
Published 22 Mar, 2021 06:19pm
What you need to know about the coronavirus right now
World

What you need to know about the coronavirus right now

  • Maharashtra, India's most industrialised state and home to its financial capital Mumbai, has been accounting for more than 60% of the country's total cases after a full-scale reopening of its economy unleashed a second wave of infections late last month.
Published 22 Mar, 2021 11:47am
Taiwan starts vaccination drive with AstraZeneca
World

Taiwan starts vaccination drive with AstraZeneca

  • The self-ruled democratic island has signed contracts to purchase 10 million AstraZeneca doses, as well as around 5 million doses each from Moderna and the international Covax scheme.
Published 22 Mar, 2021 10:47am
French regulators recommends AstraZeneca for over-55s after suspension
World

French regulators recommends AstraZeneca for over-55s after suspension

  • France was one of more than a dozen European Union states that suspended use of the Anglo-Swedish vaccine this week following reports of blood clotting in a small number of recipients of the shot.
  • The EU's drug watchdog (EMA) on Thursday said it was convinced the benefits of the AstraZeneca vaccine outweighed the risks.
Published 19 Mar, 2021 08:12pm